Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 7;6(7):e1144.
doi: 10.1002/hsr2.1144. eCollection 2023 Jul.

Transplacental transfer of Remdesivir and GS-441524: An ex vivo perfusion study

Margaux Louchet  1 , Mégane Ribot  1 , Naïm Bouazza  2 , Frantz Foissac  2 , Léo Froelicher  1 , Victoria Buth  3 , Sihem Benaboud  1 , Jean-Marc Treluyer  1   2   3 , Gabrielle Lui  1   3
Affiliations

Transplacental transfer of Remdesivir and GS-441524: An ex vivo perfusion study

Margaux Louchet et al. Health Sci Rep. .
No abstract available

Keywords: GS‐441524; Remdesivir; ex vivo cotyledon perfusion; placenta; transplacental transfer.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Remdesivir and GS‐441524 transfer.
See this image and copyright information in PMC

References

    1. Brown AJ, Won JJ, Graham RL, et al. Broad spectrum antiviral Remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase. Antiviral Res. 2019;169:104541. - PMC - PubMed
    1. Agostini ML, Andres EL, Sims AC, et al. Coronavirus susceptibility to the antiviral Remdesivir (GS‐5734) is mediated by the viral polymerase and the proofreading exoribonuclease. mBio. 2018;9(2):1. - PMC - PubMed
    1. Gilead R. Summary on Compassionate Use. European Medicines Agency.
    1. Westhoff WJ, Smith LH, Wyszynski DF, Hernandez‐Diaz S. COVID‐19 pharmacotherapy utilization patterns during pregnancy: international registry of coronavirus exposure in pregnancy. Pharmacoepidemiol Drug Saf. 2022;31(7):804‐809. - PMC - PubMed
    1. Marzban‐Rad S, Ghafarzadeh M, Bahmani S, Kazemi A. The use of Remdesivir among pregnant women and associated clinical outcomes in mother and the child. Ann Med Surg. 2022;77:103681. - PMC - PubMed

LinkOut - more resources